Related Experiment Video
Updated: Feb 26, 2026

Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
Published on: March 7, 2019
Leisure time physical activity and risk of prostate cancer: a dose-response meta-analysis
Feng Liu1, Jing Wang2, Hai-Long Wu1
1Department of Surgery, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Introduction:
Physical activity (PA) may be a protect factor against prostate cancer (PCa). We aim to investigate and establish the potential relationship between leisure time PA and PCa.
Evidence Acquisition:
PubMed, Embase databases were searched for eligible studies (cohort) before Aug-11, 2016. We conducted a meta-analysis to pool the dose-specific effects between leisure time PA and PCa. Subgroup analysis was employed to investigate the potential variation among each group. Sensitivity analysis was used to examine whether our results were stable.
Evidence Synthesis:
Twenty-one cohort studies were identified, with a total of 803,872 subjects and 28,707 PCa cases. In our meta-analysis, no obvious evidence of non-linear relationship was observed. The RRs of each 500 MET-s/week increment of leisure time PA was 1.00 (95% CI: 0.99-1.01) for total PCa, 1.00 (95% CI: 0.98-1.01) for local PCa, and 1.00 (95% CI: 0.98-1.02) for advanced PCa. In subgroup analysis, for Americans, the RR of each 500 MET-s/week increment of leisure time PA was 1.00 (95% CI: 0.99-1.01); and for Europeans the RR was 1.00 (95% CI: 0.99-1.01). Sensitivity analysis suggested our results were stable.
Conclusions:
Current evidence based on observational studies suggests no obvious association between leisure time activity and risk of prostate cancer, regardless of total PCa, local PCa, or advanced PCa.
More Related Videos
Related Concept Videos
Dose-Response Relationship: Overview
Cancer Prevention
Some...
Dose-Response Relationship: Potency and Efficacy
Dose Response Curve: Conventional Versus Nonmonotonic
Hazard Ratio
For example, in a clinical trial...
Dose-Response Relationship: Selectivity and Specificity

